Purchase Order N0017317P3064

This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 21 (VISN 21), a civilian agency within the Department of Veterans Affairs, to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The contract is for the supply of LENALIDOMIDE 5MG NDC: 76282-0697-48, a cancer medication, with a ceiling value of $18,697.14 and a completion date of November 23, 2025. The contract was competitively awarded and does not have...

The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 4, awarded a $1.39 million firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on May 1, 2024, for the supply of FDG (fluorodeoxyglucose) and NEURACEQ (florbetaben F-18) radiopharmaceuticals. These PET (positron emission tomography) imaging agents are critical diagnostic tools used for oncology imaging and Alzheimer's disease detection, respectively, supporting the VA's medical imaging...

<p>Amerisourcebergen Drug Corp will deliver BENLYSTA 200 MG/ML autoinjectors under a $2,701.35 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical on October 16, 2023. Performance will occur in Conshohocken, Pennsylvania by the November 6, 2023 completion date. No set-aside designation was applied to this order for pharmaceutical products placed against an unspecified agency-wide contract vehicle.</p>

This delivery order award provides for the supply of AVONEX 30 MCG/0.5 ML syringes in four-pack quantities to support federal healthcare needs. The contract was competitively awarded to AmerisourceBergen Drug Corp on January 20, 2026, with a ceiling value of $12,674.76 and an ultimate completion date of January 21, 2026. The award carries firm fixed-price terms and includes no set-aside designation, indicating open competition among qualified pharmaceutical distributors. Performance will be...

This is a $22,061.05 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics in fiscal year 2025. The contract has no set-aside designation, indicating open competition. Biologics, Inc. is a pharmaceutical company focused on delivering critical medical treatments, particularly cancer medications, to various federal healthcare and correctional...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $10,869.15 delivery order to Biogen U.S. Corporation under the company's Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule contract. The firm fixed price order is for QALSODY (TOFERSEN) 6.7MG SOLN NDC: 64406-0109-01, with an anticipated completion date of April 13, 2024. Place of performance will be in Cambridge, Massachusetts. No set-aside designation was used for this order....

The Defense Logistics Agency awarded a $21,786.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pre-filled pens, a biologic immunosuppressant used to treat autoimmune conditions. This non-set-aside award, issued on November 13, 2025, with completion targeted for November 14, 2025, represents a time-sensitive medical supply delivery to support federal healthcare needs. The order will be fulfilled from AmerisourceBergen's corporate headquarters...

This federal contract award SPE2DB22D1106|SPE2DB24FETA9, with a ceiling value of $69,475.10, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TREMFYA 100 MG/ML INJECTORML, a medical product, with a period of performance through May 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...

The Defense Logistics Agency awarded a delivery order valued at $16,286.99 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, a biologic medication used primarily to treat inflammatory conditions such as psoriasis and psoriatic arthritis. This competitively awarded, firm fixed-price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Benlysta 200 mg/mL auto-injector, a biological immunosuppressant medication used to treat systemic lupus erythematosus. This firm fixed-price delivery order, valued at $3,248.66, is scheduled for completion by January 20, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating...